To order print copies of our reports please visit our Mimeo Store.
Regulating Patient Health
In this comprehensive report we meticulously examine the existing disparities between cannabis testing programs across the states as they relate to other regulated products, with a particular focus on their impact on patient health. Our aim is to shed light on the pressing issues surrounding cannabis testing by identifying potential contaminants that could impact the health and well-being of patients and to advocate for enhanced regulations and accurate labeling of cannabis products that help safeguard public health.
2022 State of States report
Each year, Americans for Safe Access, the nation’s largest nonprofit that represents medical cannabis patients, doctors, and researchers, prepares a report that assesses legislative and regulatory improvements in medical cannabis programs across the country. This comprehensive report provides a detailed analysis of the state of medical cannabis programs in the 50 states, the District of Columbia, and four U.S. territories on an ‘A’ to ‘F’ scale.
Cannabis and Cannabis Resin- Critical Review Preparation Document
A review of Medical Cannabis by ASA's 2016 National Medical Cannabis Unity Conference for presentation to the United Nations Special Assembly
Medical Cannabis Access for Pain Treatment
A viable strategy to address the opioid crisis utilizing medical cannabis
The DEA’s Denial of Existing Medical Cannabis Research
This report attempts to correct errors present in the DEA's argument on why not to reschedule cannabis
Medical Cannabis as a Tool to Combat Pain and Opioid Crisis
Using medical cannabis to treat chronic pain is supported by research and medical professionals, and has demonstrated positive public health outcomes.
Scheduling Cannabis: A Preparatory Document for FDA’s 8-Factor Analysis on Cannabis
The 8-Factor analysis is a guide for addressing the DEA's requirements for rescheduling and regulating Cannabis as a safe and effective medicine.
What's the Cost? The Federal War on Patients
Our research found that the federal government spent nearly $500 million on raids, federal prosecutions, incarceration, and asset forfeiture suits related to medical marijuana.
Our old reports
Share this page